Rodríguez-Carreiro, S., Muñoz, E., Fernández Ruiz, J. J., & Navarro González De Mesa, E. (2023). The Cannabigerol Derivative VCE-003.2 Exerts Therapeutic Effects in 6-Hydroxydopamine-Lesioned Mice: Comparison with The Classic Dopaminergic Replacement Therapy.
Citación estilo ChicagoRodríguez-Carreiro, Santiago, Eduardo Muñoz, José Javier Fernández Ruiz, y Elisa Navarro González De Mesa. The Cannabigerol Derivative VCE-003.2 Exerts Therapeutic Effects in 6-Hydroxydopamine-Lesioned Mice: Comparison With The Classic Dopaminergic Replacement Therapy. 2023.
Cita MLARodríguez-Carreiro, Santiago, Eduardo Muñoz, José Javier Fernández Ruiz, y Elisa Navarro González De Mesa. The Cannabigerol Derivative VCE-003.2 Exerts Therapeutic Effects in 6-Hydroxydopamine-Lesioned Mice: Comparison With The Classic Dopaminergic Replacement Therapy. 2023.